- βFreeze-all IVF did not significantly improve healthy baby rates compared to fresh transfer in normal responders
- βFrozen embryo transfer reduced OHSS risk and may benefit high responders specifically
- βFresh transfer was more cost-effective in the UK NHS setting, with implications for US self-pay patients
| Country | UK |
| Journal | Human reproduction (Oxford, England) |
| Year | 2022 |
| Authors | Maheshwari, Bell, Bhide |
| PMID | 34999830 |
UK Trial Challenges the 'Freeze-All' IVF Approach β What It Means for American Fertility Patients
A study from the United Kingdom offers important new evidence for couples navigating IVF treatment decisions β particularly the increasingly popular strategy of freezing all embryos before transfer. Conducted across 18 NHS fertility clinics from 2016 to 2019, the E-Freeze trial is one of the most rigorous head-to-head comparisons of elective frozen embryo transfer (FET) versus traditional fresh embryo transfer ever completed.
What the Study Found
Researchers at Aberdeen Fertility Centre, NHS Grampian, and the University of Aberdeen enrolled 619 couples undergoing their first, second, or third IVF or ICSI cycle. Participants were randomly assigned to either freeze all embryos for later transfer or proceed with a fresh embryo transfer in the same cycle.
The primary goal was a healthy baby β defined as a full-term, singleton live birth with appropriate birth weight. Results showed:
- Healthy baby rate: 20.3% in the freeze-all group vs. 24.4% in the fresh transfer group β not a statistically significant difference, but trending in favor of fresh transfer.
- Live birth rate: 28.3% (freeze-all) vs. 34.3% (fresh) β again, no statistically significant difference, but directionally favoring fresh transfer.
- Miscarriage rate: 14.3% vs. 12.9% β essentially equivalent between groups.
- Ovarian hyperstimulation syndrome (OHSS): 3.6% in freeze-all vs. 8.1% in fresh β a meaningful safety advantage for freezing, though the difference did not reach statistical significance in this trial.
Importantly, the freeze-all approach did show higher live birth rates for women classified as high responders to ovarian stimulation β a subgroup already at elevated OHSS risk. For normal responders, however, freezing all embryos offered no clear benefit and added cost and treatment delays.
What Makes This UK Research Valuable for US Patients
The United Kingdom's National Health Service provides a unique research environment: standardized care protocols across dozens of clinics, independent government funding (through the NIHR), and no financial incentive for clinics to favor one approach over another. In the US, where IVF is largely self-pay and clinic success rates influence marketing, research findings can be shaped by commercial pressures. This NHS-funded trial offers a rare commercially neutral perspective.
The freeze-all strategy has gained significant traction in American fertility clinics over the past decade, partly driven by advances in embryo freezing technology and the belief that a rested uterus improves implantation. This UK trial provides a much-needed check on that assumption for the average IVF patient.
Comparing to US Guidelines
The American Society for Reproductive Medicine (ASRM) currently does not recommend routine freeze-all cycles for all patients. Their guidance supports elective frozen transfer in specific situations β including high OHSS risk, elevated progesterone levels at trigger, or when preimplantation genetic testing is planned. The E-Freeze findings align closely with this targeted approach, reinforcing that freeze-all should be a clinical decision, not a default protocol.
Why This Matters for US Patients
If your US fertility clinic recommends a freeze-all cycle, it's worth asking why. For most patients with a normal response to stimulation medications, this UK trial suggests fresh transfer produces comparable β and possibly slightly better β results, without the added cost, time, or logistical burden of a frozen cycle. However, if you are a high responder or at risk for OHSS, a freeze-all strategy may genuinely improve both your safety and your chances of a live birth. Ask your reproductive endocrinologist which category you fall into and request a personalized recommendation backed by your specific hormone and response data.
Frozen embryo transfer is also associated with a higher risk of large-for-gestational-age babies and pre-eclampsia β risks that deserve an honest conversation with your care team regardless of which approach is chosen.
Cite This Study
Maheshwari A, Bell J, Bhide P, et al. "Elective freezing of embryos versus fresh embryo transfer in IVF: a multicentre randomized controlled trial in the UK (E-Freeze)." Human Reproduction. 2022. DOI: 10.1093/humrep/deab279. PMID: 34999830.